Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record’s latest submission and posting dates changed from July 2026 to November 2026, indicating a newer record update.
    Difference
    0.1%
    Check dated 2026-11-16T13:59:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page changes from a 403 error screen to the full ClinicalTrials.gov record for the nivolumab and stereotactic radiosurgery study, including its study details, eligibility criteria, locations, and consent forms.
    Difference
    98%
    Check dated 2026-11-09T13:49:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:46:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-26T15:00:17.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:48:37.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:54:10.000Z thumbnail image

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.